Clinical Trials Directory

Trials / Unknown

UnknownNCT02528422

The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers

The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers - A Randomized, Cross-over, Single-blind, Placebo-controlled Dose-response Study of the Acyl-ghrelin Induced Effects on GFR, Tubular Transport of Sodium and Water in Different Nephron Segments and Central and Peripheral Blood Pressure

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Erling Bjerregaard Pedersen · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Ghrelin (growth hormone release inducer) is produced in the stomach. The active form of Ghrelin is Acyl-Ghrelin. Acyl-Ghrelin stimulates the Ghrelin receptors. Ghrelin receptors are detected in the distal tubules in mice and animal studies have shown that Ghrelin increases the absorption of sodium in the renal tubules. Ghrelin infusion directly into the renal artery of rats increased sodium reabsorption in the distal nephron, presumably via the epithelial sodium channels (ENaC). The purpose of the study is to measure the acyl-ghrelin induced effects on GFR, tubular transport of sodium and water in different nephron segments and central and peripheral blood pressure in a randomized, cross-over, single-blind, placebo-controlled dose-response study.

Conditions

Interventions

TypeNameDescription
DRUGAcyl-Ghrelin

Timeline

Start date
2015-05-01
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2015-08-19
Last updated
2015-08-19

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02528422. Inclusion in this directory is not an endorsement.